DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE Trademark

Trademark Overview


On Thursday, July 25, 2019, a trademark application was filed for DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE with the United States Patent and Trademark Office. The USPTO has given the DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE trademark a serial number of 88537082. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 7, 2020. This trademark is owned by Bayer HealthCare Pharmaceuticals Inc.. The DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE trademark is filed in the Insurance & Financial Services category with the following description:

Financial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs
dude access services darolutamide user drug experience

General Information


Serial Number88537082
Word MarkDUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE
Filing DateThursday, July 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"ACCESS SERVICES" AND "DAROLUTAMIDE USER" AND "DRUG"
Description of MarkThe mark consists of the word "DUDE" with a curved line and a dot over the second "D". Above the word "DUDE" is the phrase "ACCESS SERVICES" and below that is the phrase "Darolutamide User Drug Experience".
Goods and ServicesFinancial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, August 2, 2019
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBayer HealthCare Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWhippany, NJ 07981

Party NameBayer HealthCare Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWhippany, NJ 07981

Trademark Events


Event DateEvent Description
Tuesday, September 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 7, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 4, 2019ASSIGNED TO LIE
Monday, October 28, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 22, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, August 22, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, August 22, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, August 22, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, August 19, 2019ASSIGNED TO EXAMINER
Saturday, August 3, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, August 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 29, 2019NEW APPLICATION ENTERED IN TRAM